Drugs / TEGLARINAD
last change Aug 2010 re-read 3 minutes ago

TEGLARINAD

Small molecule targets NAMPT via inhibition

Developed for
lymphoma
Investigated by
Gemin X

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00457574 Mar 2007 → Jul 2009 lymphoma Gemin X Withdrawn No outcome recorded Stop: Business

Evidence & citations 12 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as TEGLARINAD ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as Chlorure de teglarinad ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as Cloruro de teglarinad ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as EB-1627 ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as GMX1777 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00457574 ↗
Known as Teglarinad cation ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as TEGLARINAD CHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Known as Teglarinad ion ChEMBL registry synonym — accepted as the source's own label CHEMBL1181731 ↗
Action Inhibit “Nicotinamide phosphoribosyltransferase inhibitor” CHEMBL1181731 ↗
Modality Small molecule — CHEMBL1181731 ↗
Route Intravenous “GMX1777 is a water-soluble, intravenously-administered prodrug of GMX1778.” NCT00457574 ↗
Target NAMPT “Nicotinamide phosphoribosyltransferase inhibitor” CHEMBL1181731 ↗